Wuhan (Novel) Corona Virus -looming pandemy of deadly pneumonia? - Pandemy ongoing!

(December 15, 2020) Applying AI to global health challenges: Gates Foundation awards $4.2m to Exscientia
UK-based artificial intelligence (AI) drug discovery company Exscientia has received a $4.2m two-year grant from the Bill and Melinda Gates Foundation
to apply its two Centaur platforms to three global health challenges: malaria, tuberculosis (TB), and non-hormonal contraception.
Exscientia’s AI platforms – Centaur Biologist and Centaur Chemist – will be leveraged to identify new next-generation targets
and leads for these unmet needs in infectious disease and family planning.
Exscientia portfolio manager Dr Denise Barrault explains that Centaur Biologist focuses on “identifying and quantifying new targets…for new therapies”.
The platform leverages “large data sets from the literature, large-scale repositories, like genetic repositories,
and other relevant data, including privately owned data if we can access it,” Barrault says.

(December 15, 2020) INOVIO to Develop dMAb COVID Treatments under DARPA Grant
INOVIO and a team of scientists from The Wistar Institute, AstraZeneca, the University of Pennsylvania, and Indiana University
received a $37.6 million grant from the U.S. Defense Advanced Research Projects Agency (DARPA),
to use INOVIO's DNA-encoded monoclonal antibody (dMAb) technology to develop anti-SARS-CoV-2-specific dMAbs,
which could offer versatile capabilities to function as both a therapeutic and preventive treatment for COVID-19.
As part of DARPA's two-year grant, INOVIO and Wistar teams will construct COVID-19 dMAb candidates mirroring AstraZeneca's
traditional recombinant monoclonal antibody candidates currently being tested in clinical trials to treat COVID-19.
The company can encode the DNA sequence for a specific monoclonal antibody in a DNA plasmid and deliver the plasmid directly into cells
of the body using the company's proprietary smart device called CELLECTRA.

(December 10, 2020) Who was Brandy Vaughan? Anti-vaxxer who founded non-profit Learn the Risk discovered dead by 9-year-old son
An anti-vaxxer activist Brandy Vaughan, who founded Learn the Risk, has been found dead by her nine-year-old son.
The exact date of her death is presently unknown as the news of her passing has been circulating since Tuesday, December 8.
Vaughan was an activist who founded California non-profit Learn the Risk in 2015,
which is known for its billboard campaigns asserting vaccines are responsible for a large number of deaths of young children.

How it started vs. how it's going. pic.twitter.com/vgT15sBKWz

— Ian Miles Cheong (@stillgray) December 18, 2020

MUST WATCH: Nurse faints after getting the COVID-19 vaccine while talking about how excited she is to get it.pic.twitter.com/l0TsZoxALl

— Mike Coudrey (@MichaelCoudrey) December 18, 2020

Good luck with your COVID jab! I won't take one. Just sayin'...

zerohedge
@zerohedge
·
6m
Brazil's Supreme Court Rules COVID Vaccine Can Be Mandatory

https://www.zerohedge.com/covid-19/brazils-supreme-court-rules-covid-vaccine-can-be-mandatory

(December 17, 2020) Canada announces additional support for equitable access to COVID-19 tests, treatments and vaccines
The Minister of International Development Karina Gould today announced a contribution of $230 million to procure COVID-19 treatments for developing countries
in response to urgent priorities identified by the Access to COVID-19 Tools (ACT) Accelerator, launched by the World Health Organization and partners.
The initiative builds on the important work done with the COVID-19 Therapeutics Accelerator via the Bill & Melinda Gates Foundation
to secure manufacturing capacity for novel antibody therapeutics production dedicated to developing countries.
Minister Gould also announced that Canada will invest $255 million in additional support for the ACT-Accelerator
for the effective deployment of medical solutions against COVID-19 in developing and vulnerable countries.
This will be achieved through focused investments with the World Health Organization, the Pan American Health Organization,
the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance, for the development, delivery and distribution
of vaccines and therapeutics, including targeted support to Latin America and the Caribbean.
With today’s announcement of $485 million in support, Canada has contributed $865 million to date to partners of the ACT-Accelerator,
a coalition of international organizations and countries overseeing the development, production
and equitable distribution of affordable COVID-19 vaccines, therapeutics and diagnostics.

(December 18, 2020) BioNTech, Shanghai Fosun Pharma to Supply COVID-19 Vax to China
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co. Ltd. have signed an agreement to supply Mainland China
with an initial 100 million doses of their BNT162 mRNA-based vaccine candidate against COVID-19 in 2021,
subject to regulatory approval. Initial supply will be delivered from BioNTech’s production facilities in Germany.
In March 2020, BioNTech and Fosun Pharma announced their strategic collaboration to work jointly
on the development and commercialization of a potential COVID-19 vaccine based on BioNTech’s mRNA technology platform.

(December 18, 2020) Government of New Zealand inks agreement to purchase 10.7 million doses of Novavax’s adjuvanted protein vaccine candidate, NVX-CoV2373 against COVID-19
Under the terms of the agreement, Novavax will manufacture NVX-CoV2373 with a target of delivering initial doses by mid-2021.
The company will work with Medsafe, New Zealand’s regulatory agency, to obtain product approvals as needed.
Given the urgency of timely approval and delivery of vaccine during the pandemic, the regulatory review process may leverage review by prioritized regulatory bodies
such as the US Food and Drug Administration, European Medicines Agency and/or Medicines and Healthcare products Regulatory Authority in the United Kingdom.
NVX-CoV2373 is a protein-based vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease.
NVX-CoV2373 was created using Novavax’ recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein
adjuvanted with Novavax’ patented saponin-based Matrix-M to enhance the immune response and stimulate high levels of neutralizing antibodies.

(December 19, 2020) Switzerland Approves Pfizer Shot as First Covid-19 Vaccine
Switzerland has authorized Pfizer Inc.’s and BioNTech SE’s Covid-19 vaccine, the first approved for use in the country.
Switzerland had previously signed contracts with the companies for the delivery of three million vaccine doses.
The first delivery of about 100,000 doses will arrive this year, with larger batches to follow,
according to a separate statement from the Federal Office of Public Health.
The Swiss nod comes after the U.K. and U.S. among others have already approved the vaccine,
while European Union regulators will be meeting next week to decide.
The public health office said that the vaccines from Moderna and AstraZeneca
are still undergoing Swissmedic’s approval process and the latter is “unlikely” to be available until the middle of next year.

(December 18, 2020) FDA authorizes Moderna vaccine for emergency use
The Food and Drug Administration authorized emergency use of Moderna’s coronavirus vaccine Friday,
launching a second option to inoculate against the virus and adding millions of doses to the national supply.
Moderna, a ten-year-old Massachusetts biotechnology company, has never brought a product to market before.
But the company developed its potential vaccine within days of learning the virus’ genetic sequence
and began working with the National Institutes of Health to put doses into trials.
Moderna in May signed a manufacturing contract with Swiss company Lonza AG
to produce up to one billion doses of the vaccine in the next year.

Chicago-area hospital pauses vaccinations after 4 workers experience adverse reactions: report

https://www.foxnews.com/health/chicago-area-hospital-pauses-vaccinations-after-4-workers-experience-adverse-reactions-report

Anti-lockdown protest taking place now in Toronto. pic.twitter.com/dHAjX3UQeG

— Rebel News (@RebelNewsOnline) December 19, 2020

KneelB4Zod! wrote:Chicago-area hospital pauses vaccinations after 4 workers experience adverse reactions: report

https://www.foxnews.com/health/chicago-area-hospital-pauses-vaccinations-after-4-workers-experience-adverse-reactions-report

There was a ZH article the other day saying 40 per cent of staff at one Chicago hospital were refusing the vaccine,obviously they were the smart ones

Brandy Vaughan

Was an activist best known for speaking out against the pharmaceutical industry and vaccines;
founder of Learn The Risk, a vaccine awareness non-profit organization. She worked for Merck between 2001-2004.
After leaving her job, Brandy Vaughan lived in Europe for 8 years with her son.
In December 2019, Brandy Vaughan explicitly stated that she would never commit suicide,
stating "I’ve NEVER had any thoughts of taking my own life, not once, ever.
Vaughan was found dead by her son on 7 December 2020.
According to some webpages, she died from gallbladder complications.
Erin Elizabeth wrote on Dec. 8 that there will be an independent autopsy,
Brandy did relate that she was fearful for attacks on her life and her house had been broken into several times.

COVID totality in Slovakia...

Slovenská republika právě teď.
- No vida, ani nejsou k zapotřebí přídělový lístky. Však vy si na ten šrot a vodu zvyknete. pic.twitter.com/eZYDY3lbj7

— Nosey George - Naštvaný (@JiriParkes) December 20, 2020

The Spectator Index
@spectatorindex
·
24m
JUST IN: Coronavirus strand in the United Kingdom, which was found to have higher transmission rate, has also been identified in Italy.

Definitely another step to enforce mandatory vaccination and COVID Passes.

The Great Covid Class War by Alex Gutentag via The Bellows https://t.co/RfdTsqD15Q

— Shawn Leigh Alexander (@S_L_Alexander) December 19, 2020

Well, that's one good point for Bolsonaro:

Wow, the Brazilian President Jair Bolsonaro is sure a straight shooter! pic.twitter.com/jlu4ktKM6z

— BeachMilk (@YellowCube7) December 20, 2020

zerohedge
@zerohedge
·
12h
2020: The Year We Sold Our Liberties For A Medical Tyranny

https://www.zerohedge.com/covid-19/2020-year-we-sold-our-liberties-medical-tyranny

Guy Elster
@guyelster
·
4m
#BREAKING Biden receives COVID-19 vaccine at live

(December 21, 2020) EU approves BioNTech-Pfizer COVID vaccine
The European Medicines Agency (EMA) and the European Commission approved the BioNTech-Pfizer coronavirus vaccine on Monday.
The EMA's positive assessment of the vaccine was widely expected.
The Amsterdam-based drug regulator was under pressure from European countries,
including Germany, to speed up its decision, which was originally scheduled for December 29.
"We granted conditional market authorization to the vaccine produced by BioNTech and Pfizer,"
European Commission President Ursula von der Leyen said in a statement, just hours after the EMA recommendation to approve the vaccine.

(December 17, 2020) Johns Hopkins leads coalition for equitable distribution of COVID-19 vaccines
The Johns Hopkins Center for Health Security at the Bloomberg School of Public Health has launched a coalition to promote equitable vaccination distribution.
The pandemic has exacerbated systemic factors that have driven longstanding health inequities among communities of color.
The CommuniVax coalition will conduct rapid ethnographic research related to COVID-19 vaccination
among historically underserved communities of color. As hard-hit communities must have an active role in the vaccination campaign,
research teams will work with community members to develop suggestions
on strengthening COVID-19 vaccine delivery and communication strategies.
The coalition will disseminate community viewpoints to national stakeholders
to develop a more equitable and effective vaccination effort.
CommuniVax received a $2 million grant from the Chan Zuckerberg Initiative to fund this research.